» Articles » PMID: 28248864

Association of Total Cholesterol and HDL-C Levels and Outcome in Coronary Heart Disease Patients with Heart Failure

Overview
Specialty General Medicine
Date 2017 Mar 2
PMID 28248864
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to evaluate associations of total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C) levels with prognosis in coronary heart disease (CHD) patients with heart failure (HF).Patients who were angiographical-diagnosis of CHD and echocardiographical-diagnosis of left ventricular ejection fraction (LVEF) < 45% were enrolled. Baseline characteristics were collected and association of TC and HDL-C levels with rehospitalization for HF and all-cause mortality was assessed.A total of 118 patients were recruited. Mean age was 58.6 ± 10.9 years and male accounted for 65%. Mean LVEF was 39.5 ± 4.0%. Twenty-eight patients were rehospitalized for HF and 6 patients were dead. In patients with poor prognosis, lower body mass index (BMI), TC, HDL-C and albumin while higher high sensitivity C-reactive protein (Hs-CRP) was observed. TC was positively correlated with BMI and albumin, and HDL-C was inversely correlated with Hs-CRP. The associations of TC level and rehospitalization for HF and all-cause mortality were attenuated but consistently significant through model 1 to 4, with odds ratio (OR) of 0.97 (95% confidence interval [CI]: 0.92-0.99). Associations of HDL-C level and rehospitalization for HF and all-cause mortality were also consistently significant through model 1 to 4, with OR of 0.95 (95% CI: 0.90-0.98). Strength of association was attenuated prominently in model 3 after adjusted for Hs-CRP, and no change was observed after further adjusted for BMI and albumin.Higher baseline TC and HDL-C levels are associated with better outcome in CHD patients with HF.

Citing Articles

Relationship between novel inflammatory markers derived from high-sensitivity C-reactive protein and heart failure: a cross-sectional study.

Zhang P, Mo D, Lin F, Dai H BMC Cardiovasc Disord. 2025; 25(1):111.

PMID: 39966719 PMC: 11837360. DOI: 10.1186/s12872-025-04558-2.


The effect of a new developed synbiotic yogurt consumption on metabolic syndrome components in adults with metabolic syndrome: a randomized controlled clinical trial.

Zolghadrpour M, Jowshan M, Seyedmahalleh M, Karimpour F, Imani H, Asghari S Nutr Diabetes. 2024; 14(1):97.

PMID: 39695092 PMC: 11655839. DOI: 10.1038/s41387-024-00354-7.


Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction.

Jiang Y, Chen X, Zhang X, Dong S, Liu Y BMC Cardiovasc Disord. 2024; 24(1):621.

PMID: 39501133 PMC: 11536577. DOI: 10.1186/s12872-024-04288-x.


The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial.

Matin S, Shidfar F, Naderi N, Amin A, Hosseini-Baharanchi F, Dehnad A Sci Rep. 2024; 14(1):19120.

PMID: 39155305 PMC: 11330970. DOI: 10.1038/s41598-024-69560-8.


High-Density Lipoprotein and Heart Failure.

Xing L, Liu Y, Wang J, Tian P, Liu P Rev Cardiovasc Med. 2024; 24(11):321.

PMID: 39076447 PMC: 11272862. DOI: 10.31083/j.rcm2411321.


References
1.
Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L . Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011; 305(16):1677-84. DOI: 10.1001/jama.2011.522. View

2.
Valentova M, von Haehling S, Bauditz J, Doehner W, Ebner N, Bekfani T . Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure. Eur Heart J. 2016; 37(21):1684-91. DOI: 10.1093/eurheartj/ehw008. View

3.
LaRosa J, Grundy S, Kastelein J, Kostis J, Greten H . Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study). Am J Cardiol. 2007; 100(5):747-52. DOI: 10.1016/j.amjcard.2007.03.102. View

4.
Horwich T, Hernandez A, Dai D, Yancy C, Fonarow G . Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. Am Heart J. 2008; 156(6):1170-6. DOI: 10.1016/j.ahj.2008.07.004. View

5.
Tavazzi L, Maggioni A, Marchioli R, Barlera S, Franzosi M, Latini R . Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372(9645):1231-9. DOI: 10.1016/S0140-6736(08)61240-4. View